These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 25672594)
1. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594 [TBL] [Abstract][Full Text] [Related]
2. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
3. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933 [TBL] [Abstract][Full Text] [Related]
4. RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles. Luo G; Jin C; Long J; Fu D; Yang F; Xu J; Yu X; Chen W; Ni Q Cancer Biol Ther; 2009 Apr; 8(7):594-8. PubMed ID: 19276660 [TBL] [Abstract][Full Text] [Related]
5. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma. Zhu DM; Li DC; Zhang ZX; Zhang XY Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330 [TBL] [Abstract][Full Text] [Related]
6. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for siRNA delivery and gene silencing. Patil Y; Panyam J Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242 [TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994 [TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth. Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580 [TBL] [Abstract][Full Text] [Related]
11. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438 [TBL] [Abstract][Full Text] [Related]
12. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating. Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045 [TBL] [Abstract][Full Text] [Related]
13. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles. Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377 [TBL] [Abstract][Full Text] [Related]
14. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis. Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222 [TBL] [Abstract][Full Text] [Related]
15. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
16. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer. Zou L; Song X; Yi T; Li S; Deng H; Chen X; Li Z; Bai Y; Zhong Q; Wei Y; Zhao X Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823 [TBL] [Abstract][Full Text] [Related]
17. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]. Liu JP; Yuan SZ; Zhang SN Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254 [TBL] [Abstract][Full Text] [Related]
18. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells. Heo MB; Cho MY; Lim YT Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635 [TBL] [Abstract][Full Text] [Related]
19. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice. Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606 [TBL] [Abstract][Full Text] [Related]
20. [Silencing hypoxia inducible factor-2α gene by small interference RNA inhibits the growth of mammosphere cells in nude mice under hypoxic microenvironment]. Qu HB; Fan YM; Han ML; Zeng N; Zhu ZK; Liu H; Xie J; Wu CY; Tang WX Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1182-7. PubMed ID: 23902893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]